Clinical Trials
5 trialsNCT00004202 2021-08-26
Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer
Spectrum Pharmaceuticals, Inc
Phase 2 Completed
NCT00005887 2021-08-23
Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases
Spectrum Pharmaceuticals, Inc
Phase 3 Completed
NCT00005855 2013-06-21
Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00055887 2013-05-10
Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer
Spectrum Pharmaceuticals, Inc
Phase 3 Withdrawn
NCT00083304 2013-05-10
ENRICH
Spectrum Pharmaceuticals, Inc
Phase 3 Completed